Figure 3From: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS studyCumulative percentage of patients to 1998 European LDL-C goal of<3.0 mmol/L [7] by dose at 16 weeks. *p < 0.05 rosuvastatin 10–40 mg vs atorvastatin 10–80 mg RSV: Rosuvastatin, ATV: Atorvastatin, LDL-C: Low-density lipoprotein cholesterolBack to article page